Intellectual disability may be either generalized (cognitive impairment) or specific to one area (learning difficulty). Children with cognitive impairment have below-average IQ, at <70.[1] The degree of cognitive impairment depends on the underlying disorder and its severity. An IQ of 50 to 70 is classed as mild cognitive impairment. Children with a specific learning difficulty, on the other hand, have difficulties with particular mental tasks but a normal IQ. Examples include difficulties with speech (specific language impairment), reading and writing (dyslexia), and use of numbers (dyscalculia). Although the terms "learning difficulty" and "cognitive impairment" have specific definitions, they are sometimes used interchangeably by clinicians.[1]
Summary
Epidemiology
Cognitive impairment affects 2-3% of children.[2] Down syndrome and fetal alcohol syndrome are among the most common identified causes of cognitive impairment.[3] The prevalence of learning difficulties is more difficult to determine because of the spectrum of disabilities and the variation in diagnostic criteria.[4] Most estimates suggest that the lifetime prevalence of learning disability is about 10%; males are more likely to be affected than females. Dyslexia is the most common specific learning disability (affecting about 5% to 12% of children).[1] [5]
The majority of conditions associated with both specific learning difficulties and generalized cognitive impairment are developmental in origin, are linked to abnormalities in brain structure and function, and are present from birth. Learning difficulty or cognitive impairment may be part of a syndrome, and there may be a family history of similar difficulties. Generalized cognitive impairment is often associated with a history of delayed developmental milestones; the age at which it becomes manifest varies according to its severity. In some children, mild generalized cognitive impairment becomes more obvious when the child starts attending school.
The English Learning Disabilities Mortality Review (LeDeR) program in 2018 found that the median age at death for 3860 people with learning disabilities (ages 4 years and over) was 60 years for males and 59 years for females.[6]
Multidisciplinary team approach
Children who develop new specific learning difficulties or who have recently been identified as having cognitive impairment should be referred to a pediatric neurologist. An acquired disability due to intracranial pathology must be considered if there is an acute onset or a regression of previously acquired skills. However, often the specific learning difficulties or cognitive impairment may have been present for some time but only recently noted (e.g., on starting school).
A multidisciplinary team (MDT) assessment is desirable for accurate diagnosis and advice regarding appropriate interventions and educational placement. An MDT assessment includes the pediatrician or child psychiatrist and allied professionals such as a psychologist and a speech therapist. Children with motor coordination difficulties (developmental coordination disorder, or dyspraxia) resulting in physical problems with writing may benefit from assessment by an occupational therapist. The role of the clinical psychologist is to identify the child's cognitive ability (IQ, or age-equivalent developmental level, which can be compared with their chronologic age). Speech therapists help assess the child's expressive and receptive (understanding) language abilities and compare these with the overall level of cognitive ability. Some children have a discrepancy between cognitive and language abilities. For example, children with autism sometimes have relatively superior nonverbal skills compared with verbal performance. There is evidence that early reading interventions may be particularly helpful in improving expressive and receptive language as well as reading in children with intellectual disability.[7]
Cerebral palsy
"Cerebral palsy" is a diagnosis given to children with a static brain injury of varying etiology (e.g., preterm birth, hypoxic-ischemic injury, meningitis, or intracerebral hemorrhage), associated with a disorder of movement and posture. Cerebral palsy is not a cause of cognitive impairment. However, the two conditions can coexist, and for this reason a cause and effect relationship is often mistakenly assumed both by clinicians and by the general public.[8]
Last updated
Citations
Harris JC. Developmental neuropsychiatry, volumes 1 and 2. Oxford, UK: Oxford University Press; 1998.
Baird G, Gringras P. Investigation of developmental delay. In: Rutter M, Bishop D, Pine D, et al. Child and adolescent psychiatry. 5th ed. Hoboken, NJ: Wiley-Blackwell; 2008.
Bellman M, Lingam S, Aukett A. Schedule of growing skills. 2nd ed. London, UK: NFER Nelson Publishing Company Ltd; 1996.
1. Harris JC. Developmental neuropsychiatry, volumes 1 and 2. Oxford, UK: Oxford University Press; 1998.
2. American Academy of Pediatrics. Caring for your school-age child ages 5 to 12. Itasca, IL: AAP Books; 2005.[Full Text]
3. Rasmussen C, Bisanz J. Executive functioning in children with fetal alcohol spectrum disorders: profiles and age-related differences. Child Neuropsychology. 2009;15:201-15.[Abstract]
4. Rey-Casserly C, McGuinn L, Lavin A, et al. School-aged children who are not progressing academically: considerations for pediatricians. Pediatrics. 2019 Oct;144(4):e20192520.[Abstract][Full Text]
5. Peterson RL, Pennington BF. Developmental dyslexia. Lancet. 2012;379:1997-2007.[Abstract][Full Text]
6. Healthcare Quality Improvement Partnership. The Learning Disabilities Mortality Review - annual report 2018. 21 May 2019 [internet publication].[Full Text]
7. Reichow B, Lemons CJ, Maggin DM, et al. Beginning reading interventions for children and adolescents with intellectual disability. Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011359.[Abstract][Full Text]
8. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 28;28(4):183-91.[Abstract]
9. Diehl JJ, Frost SJ, Sherman G, et al. Neural correlates of language and non-language visuospatial processing in adolescents with reading disability. Neuroimage. 2014;101:653-66.[Abstract][Full Text]
10. Shaywitz SE, Shaywitz BA. Dyslexia (specific reading disability). Biol Psychiatry. 2005 Jun 1;57(11):1301-9.[Abstract]
11. Norton ES, Beach SD, Gabrieli J. Neurobiology of dyslexia. Curr Opin Neurobiol. 2015;30:73-8.[Abstract][Full Text]
12. Carrion-Castillo A, Franke B, Fisher SE. Molecular genetics of dyslexia: an overview. Dyslexia. 2013;19:214-40.[Abstract][Full Text]
13. Giraud AL, Ramus F. Neurogenetics and auditory processing in developmental dyslexia. Curr Opin Neurobiol. 2013;23:37-42.[Abstract]
14. von Aster MG, Shalev RS. Number development and developmental dyscalculia. Dev Med Child Neurol. 2007 Nov;49(11):868-73.[Abstract][Full Text]
15. Antshel KM. Attention-deficit hyperactivity disorder in the context of a high intellectual quotient/giftedness. Dev Disabil Res Rev. 2008;14:293-9.[Abstract]
16. Taylor E. Developing ADHD. J Child Psychol Psychiatry. 2009;50:126-32.[Abstract]
17. Newbury DF, Paracchini S, Scerri TS, et al. Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects. Behav Genet. 2011;41:90-104.[Abstract][Full Text]
18. Bishop DV. Genes, cognition, and communication: insights from neurodevelopmental disorders. Ann N Y Acad Sci. 2009 Mar;1156(1):1-18.[Abstract][Full Text]
19. Lai CS, Fisher SE, Hurst JA, et al. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001;413:519-23.[Abstract]
20. Polatajko HJ, Cantin N. Developmental coordination disorder (dyspraxia): an overview of the state of the art. Semin Pediatr Neurol. 2005;12:250-8.[Abstract]
21. Gibbs J, Appleton J, Appleton R. Dyspraxia or developmental coordination disorder? Unravelling the enigma. Arch Dis Child. 2007;92:534-9.[Abstract]
22. Steinman KJ, Mostofsky SH, Denckla MB. Toward a narrower, more pragmatic view of developmental dyspraxia. J Child Neurol. 2010;25:71-81.[Abstract][Full Text]
23. Silverman W. Down syndrome: cognitive phenotype. Ment Retard Dev Disabil Res Rev. 2007;13:228-36.[Abstract]
24. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol. 1996;38:191-202.[Abstract]
25. Visootsak J, Warren ST, Anido A, et al. Fragile X syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila). 2005 Jun;44(5):371-81.[Abstract]
26. Tsai AC, Pickler L, Tartaglia N, et al. Chromosomal disorders and fragile X syndrome. In: Developmental-behavioral pediatrics, 4th ed, Carey WB, Crocker AC, Coleman WL, et al (Eds). Saunders Elsevier, Philadelphia; 2009: 224.
27. Hagerman RJ. Fragile-X chromosome and learning disability. J Am Acad Child Adolesc Psychiatry. 1987;26:938.[Abstract]
28. Hagerman RJ. Annotation: fragile X syndrome: advances and controversy. J Child Psychol Psychiatry. 1992;33:1127-39.[Abstract]
29. Consensus of the Fragile X Clinical & Research Consortium on Clinical Practices. Autism spectrum disorder in fragile X syndrome. Nov 2014 [internet publication]. [Full Text]
30. McCandless SE; Committee on Genetics. Clinical report - health supervision for children with Prader-Willi syndrome. Pediatrics. 2011;127:195-204.[Abstract][Full Text]
31. Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet. 2003;40:87-95. [Abstract][Full Text]
32. Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130:517-28.[Abstract][Full Text]
33. Al Ageeli E, Drunat S, Delanoë C, et al. Duplication of the 15q11-q13 region: clinical and genetic study of 30 new cases. Eur J Med Genet. 2014;57:5-14.[Abstract]
34. Martens MA, Wilson SJ, Reutens DC. Research Review: Williams syndrome: a critical review of the cognitive, behavioral, and neuroanatomical phenotype. J Child Psychol Psychiatry. 2008;49:576-608.[Abstract]
35. Naidu S, Bibat G, Kratz L, et al. Clinical variability in Rett syndrome. J Child Neurol. 2003;18:662-8.[Abstract]
36. Nomura Y, Segawa M. Natural history of Rett syndrome. J Child Neurol. 2005;20:764-8.[Abstract]
37. Ross J, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:135-41.[Abstract]
38. Prather P, de Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J Child Neurol. 2004 Sep;19(9):666-74.[Abstract]
39. Antshel KM, Fremont W, Kates WR. The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective. Dev Disabil Res Rev. 2008;14:43-51.[Abstract]
40. Hanson E, Nasir RH, Fong A, et al. Cognitive and behavioral characterization of 16p11.2 deletion syndrome. J Dev Behav Pediatr. 2010;31:649-57.[Abstract]
41. Hanson E, Bernier R, Porche K, et al. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biol Psychiatry. 2015;77:785-93.[Abstract][Full Text]
42. Moreno-De-Luca A, Evans DW, Boomer KB, et al. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry. 2015;72:119-26.[Abstract][Full Text]
43. Bai D, Yip BHK, Windham GC, et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry. 2019 Oct 1;76(10):1035-43.[Abstract][Full Text]
44. Volkmar FR, Lord C, Bailey A, et al. Autism and pervasive developmental disorders. J Child Psychol Psychiatry. 2004 Jan;45(1):135-70.[Abstract]
45. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: recognition, referral and diagnosis. Dec 2017 [internet publication].[Abstract][Full Text]
46. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
47. Hyman SL, Levy SE, Myers SM; Committee On Psychosocial Aspects of Child and Family Health, Section On Developmental and Behavioral Pediatrics. Executive summary: identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020 Jan;145(1):e20193448.[Abstract][Full Text]
48. Swineford LB, Thurm A, Baird G, et al. Social (pragmatic) communication disorder: a research review of this new DSM-5 diagnostic category. J Neurodev Disord. 2014;6:41.[Abstract][Full Text]
49. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med. 2007;12:154-9.[Abstract]
50. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med. 2007;12:214-23.[Abstract]
51. Best JM. Rubella. Semin Fetal Neonatal Med. 2007;12:182-92.[Abstract]
52. O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J Paediatr Child Health. 2004;40:2-7.[Abstract]
53. Williams JH, Ross L. Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry. 2007;16:243-53.[Abstract]
54. Harden CL. Antiepileptic drug teratogenesis: what are the risks for congenital malformations and adverse cognitive outcomes? Int Rev Neurobiol. 2008;83:205-13.[Abstract]
55. Walker DM, Marlow N. Neurocognitive outcome following fetal growth restriction. Arch Dis Child Fetal Neonatal Ed. 2008;93:F322-5.[Abstract]
56. Delobel-Ayoub M, Arnaud C, White-Koning M, et al. Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics. 2009;123:1485-92.[Abstract]
57. Rennie JM, Hagmann CF, Robertson NJ. Outcome after intrapartum hypoxic ischaemia at term. Semin Fetal Neonatal Med. 2007;12:398-407.[Abstract]
58. Pin TW, Eldridge B, Galea MP. A review of developmental outcomes of term infants with post-asphyxia neonatal encephalopathy. Eur J Paediatr Neurol. 2009;13:224-34.[Abstract]
59. Carter JA, Neville BG, Newton CR. Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res Brain Res Rev. 2003;43:57-69.[Abstract]
60. Fellick JM, Sills JA, Marzouk O, et al. Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child. 2001;85:6-11.[Abstract][Full Text]
61. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399-408.[Abstract]
62. Jayawant S, Parr J. Outcome following subdural haemorrhages in infancy. Arch Dis Child. 2007;92:343-7.[Abstract]
63. Johnson AR, DeMatt E, Salorio CF. Predictors of outcome following acquired brain injury in children. Dev Disabil Res Rev. 2009;15:124-32.[Abstract]
64. Slomine B, Locascio G. Cognitive rehabilitation for children with acquired brain injury. Dev Disabil Res Rev. 2009;15:133-43.[Abstract]
65. Kriel RL, Krach LE, Luxenberg MG, et al. Outcome of severe anoxic/ischemic brain injury in children. Pediatr Neurol. 1994;10:207-12.[Abstract]
66. Jackson DC, Dabbs K, Walker NM, et al. The neuropsychological and academic substrate of new/recent-onset epilepsies. J Pediatr. 2013;162:1047-53;e1.[Abstract][Full Text]
67. Masur D, Shinnar S, Cnaan A, et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology. 2013;81:1572-80.[Abstract][Full Text]
68. Turner SJ, Morgan AT, Perez ER, et al. New genes for focal epilepsies with speech and language disorders. Curr Neurol Neurosci Rep. 2015;15:35.[Abstract]
69. Sánchez Fernández I, Chapman KE, Peters JM, et al. Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management. Epilepsy Res Treat. 2013;2013:583531.[Abstract][Full Text]
70. Rose SR, Wassner AJ, Wintergerst KA, et al. Congenital hypothyroidism: screening and management. Pediatrics. 2023 Jan; 151(1): e2022060419.[Full Text]
71. NHS England. Laboratory guide to screening for CHT in the UK: screening protocol. Oct 2020 [internet publication].[Full Text]
72. Jones DE, Hart K, Shapira SK, et al. Identification of primary congenital hypothyroidism based on two newborn screens - Utah, 2010-2016. MMWR Morb Mortal Wkly Rep. 2018 Jul 20;67(28):782-5.[Abstract][Full Text]
73. van Wegberg AMJ, MacDonald A, Ahring K, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017 Oct 12;12(1):162.[Abstract][Full Text]
74. Rutter M. Developmental catch-up, and deficit, following adoption after severe global early privation: English and Romanian Adoptees (ERA) Study Team. J Child Psychol Psychiatry. 1998;39:465-76.[Abstract]
75. Beckett C, Maughan B, Rutter M, et al. Do the effects of early severe deprivation on cognition persist into early adolescence? Findings from the English and Romanian adoptees study. Child Dev. 2006;77:696-711.[Abstract]
76. Baird G, Gringras P. Investigation of developmental delay. In: Rutter M, Bishop D, Pine D, et al. Child and adolescent psychiatry. 5th ed. Hoboken, NJ: Wiley-Blackwell; 2008.
77. Bellman M, Lingam S, Aukett A. Schedule of growing skills. 2nd ed. London, UK: NFER Nelson Publishing Company Ltd; 1996.
78. Horridge KA. Assessment and investigation of the child with disordered development. Arch Dis Child Educ Pract Ed. 2011;96:9-20.[Abstract]
79. Michelson DJ, Shevell MI, Sherr EH, et al. Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77:1629-35.[Full Text]
80. Dyckhoff-Shen S, Koedel U, Pfister HW, Klein M. SOP: emergency workup in patients with suspected acute bacterial meningitis. Neurol Res Pract. 2021 Jan 7;3(1):2.[Abstract][Full Text]
81. Cabellos C, Verdaguer R, Olmo M, et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore). 2009 Mar;88(2):115-9.[Abstract][Full Text]
82. Choi C. Bacterial meningitis in aging adults. Clin Infect Dis. 2001 Oct 15;33(8):1380-5.[Abstract][Full Text]
83. American Academy of Neurology. Chromosomal microarray analysis for intellectual disabilities. 2013 [internet publication].[Full Text]
84. Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-57.[Abstract][Full Text]
85. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6:265ra168.[Abstract]
86. Nussbaum R, McInnes R, Willard H, et al. Thompson & Thompson genetics in medicine, 6th ed. Philadelphia, PA: Saunders; 2004:157-79.
87. Hunter AGW. Down syndrome. In: Cassidy SB, Allanson JE, eds. Management of genetic syndromes, 2nd ed. Hoboken, NJ: Wiley-Liss; 2005:191-210.
88. Irving CA, Chaudhari MP. Cardiovascular abnormalities in Down's syndrome: spectrum, management and survival over 22 years. Arch Dis Child. 2012 Apr;97(4):326-30.[Abstract][Full Text]
89. Weijerman ME, van Furth AM, Vonk Noordegraaf A, et al. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. 2008 Jan;152(1):15-9.[Abstract]
90. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-8.[Abstract]
